Abbott Vascular says it will approach FDA to design a U.S. clinical trial for its bioabsorbable everolimus-eluting stent once it gets data from a few hundred more patients in its overseas trials
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Openwater is currently focusing on EMS applications of its AI-powered stroke detection technology, both in-hospital and prehospital, such as in ambulances and urgent care centers.
Tala Fakhouri said the agency’s use of the AI tool in the review process has generated lots of questions.
Ahead of the ADA conference, Abbott announced Tandem as the fourth partner to integrate Abbott’s dual glucose-ketone sensor with automated insulin delivery. Expanded Medicare CGM coverage, FDA label expansions and new ADA guidelines position Abbott to grow its CGM footprint in a competitive market.
